Attached files

file filename
8-K - 8-K - AXCELIS TECHNOLOGIES INCa13-19474_48k.htm

Exhibit 99.1

 

News Release

GRAPHIC

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER 2013

 

BEVERLY, Mass. — November 6, 2013—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the quarter ended September 30, 2013. Highlights for the quarter were:

 

·                  System sales were $20.2 million, a 22% increase over the second quarter of 2013, and a 59% increase over the first quarter.

 

·                  System bookings were up 60% and System backlog was up 35% from the second quarter 2013.

 

·                  The Company recognized revenue on its first Purion M medium current implanter.

 

The Company reported third quarter revenue of $48.8 million, compared to $47.5 million for the second quarter of 2013. Operating loss for the quarter was $2.8 million, compared to $3.4 million for the second quarter.  Net loss for the quarter was $4.8 million, or ($0.04) per share.  This compares to a net loss for the second quarter of 2013 of $4.0 million, or ($0.04) per share. Cash, cash equivalents and restricted cash were $50.7 million at September 30, 2013 compared with $34.7 million at June 30, 2013.

 

Chairman and CEO Mary Puma said, “The Purion platform continues to gain traction, our balance sheet is healthy, and Axcelis is well positioned to capitalize on the industry upturn.  We expect to return to profitability in the fourth quarter.  We also expect that during the current upturn we will return to our last quarterly peak revenues and maintain profitability through the cycle.”

 

Third Quarter 2013 Conference Call

 

The Company will host a conference call today at 5:00 pm ET to discuss results for the third quarter of 2013.  An audio webcast will be available on the Investor page of Axcelis’ website at www.axcelis.com, or by dialing 1.888.680.0878 (1.617.213.4855 outside North America).  Participants calling into the conference call will be requested to provide the passcode:  47494360. A replay of the webcast will be available for 30 days following the conference call.

 



 

Safe Harbor Statement

 

This press release and the conference call contain forward-looking statements under the SEC safe harbor provisions. These statements, which include our guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis

 

Axcelis Technologies, Inc. (Nasdaq: ACLS) headquartered in Beverly, Massachusetts, has been providing  innovative, high-productivity solutions for the semiconductor industry for over 35 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation, one of the most critical and enabling steps in the IC manufacturing process.  The Company’s Internet address is: www.axcelis.com.

 

Company Contacts

 

Investor Relations:

Doug Lawson
978.787.9552

 

Editorial/Media:

Maureen Hart
978.787.4266

 



 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three months ended

 

Nine months ended

 

 

 

September 30,

 

September 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

Revenue

 

 

 

 

 

 

 

 

 

Product

 

$

42,934

 

$

37,093

 

$

118,151

 

$

136,096

 

Services

 

5,897

 

7,547

 

18,907

 

22,664

 

Total revenue

 

48,831

 

44,640

 

137,058

 

158,760

 

Cost of revenue

 

 

 

 

 

 

 

 

 

Product

 

27,339

 

24,809

 

74,976

 

84,692

 

Services

 

4,516

 

5,464

 

15,427

 

16,377

 

Total cost of revenue

 

31,855

 

30,273

 

90,403

 

101,069

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

16,976

 

14,367

 

46,655

 

57,691

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research and development

 

8,148

 

9,851

 

25,857

 

31,999

 

Sales and marketing

 

5,330

 

5,470

 

16,128

 

18,284

 

General and administrative

 

6,164

 

6,325

 

19,165

 

20,611

 

Gain on sale of dry strip assets and intellectual property

 

 

 

(1,167

)

 

Restructuring charges

 

112

 

578

 

2,334

 

3,612

 

Total operating expenses

 

19,754

 

22,224

 

62,317

 

74,506

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(2,778

)

(7,857

)

(15,662

)

(16,815

)

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Interest income

 

3

 

9

 

8

 

27

 

Interest expense

 

(193

)

 

(308

)

 

Other, net

 

(1,252

)

(627

)

(671

)

(999

)

Total other income (expense)

 

(1,442

)

(618

)

(971

)

(972

)

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

(4,220

)

(8,475

)

(16,633

)

(17,787

)

 

 

 

 

 

 

 

 

 

 

Income taxes

 

530

 

243

 

1,125

 

1,429

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(4,750

)

$

(8,718

)

$

(17,758

)

$

(19,216

)

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

$

(0.04

)

$

(0.08

)

$

(0.16

)

$

(0.18

)

 

 

 

 

 

 

 

 

 

 

Shares used in computing net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted weighted average common shares

 

109,074

 

107,855

 

108,573

 

107,521

 

 



 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands)

(Unaudited)

 

 

 

September 30,
2013

 

December 31,
2012

 

ASSETS

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

48,317

 

$

44,986

 

Accounts receivable, net

 

29,321

 

24,843

 

Inventories, net

 

94,316

 

100,234

 

Restricted cash

 

1,583

 

106

 

Prepaid expenses and other current assets

 

5,066

 

5,056

 

Total current assets

 

178,603

 

175,225

 

 

 

 

 

 

 

Property, plant and equipment, net

 

32,311

 

34,413

 

Restricted cash, long-term

 

825

 

 

Other assets

 

15,542

 

12,520

 

Total assets

 

$

227,281

 

$

222,158

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

 

$

16,075

 

$

10,166

 

Accrued compensation

 

7,309

 

7,283

 

Warranty

 

1,461

 

1,700

 

Income taxes

 

262

 

278

 

Deferred revenue

 

3,911

 

6,423

 

Current portion of long-term debt

 

185

 

 

Other current liabilities

 

4,250

 

3,932

 

Total current liabilities

 

33,453

 

29,782

 

 

 

 

 

 

 

Long-term debt

 

14,815

 

 

Long-term deferred revenue

 

154

 

456

 

Other long-term liabilities

 

6,129

 

5,844

 

Total liabilities

 

54,551

 

36,082

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred stock, $0.001 par value, 30,000 shares authorized; none issued or outstanding

 

 

 

Common stock, $0.001 par value, 300,000 shares authorized; 109,586 shares issued and 109,466 shares outstanding at September 30, 2013;108,293 shares issued and 108,173 shares outstanding at December 31, 2012

 

110

 

108

 

Additional paid-in capital

 

508,976

 

504,643

 

Treasury stock, at cost, 120 shares at September 30, 2013 and December 31, 2012

 

(1,218

)

(1,218

)

Accumulated deficit

 

(340,235

)

(322,477

)

Accumulated other comprehensive income

 

5,097

 

5,020

 

Total stockholders’ equity

 

172,730

 

186,076

 

Total liabilities and stockholders’ equity

 

$

227,281

 

$

222,158

 

 



 

Axcelis Technologies, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Nine months ended

 

 

 

September 30,

 

 

 

2013

 

2012

 

Cash flows from operating activities

 

 

 

 

 

Net loss

 

$

(17,758

)

$

(19,216

)

Adjustments to reconcile net loss to net cash used for operating activities:

 

 

 

 

 

Depreciation and amortization

 

3,948

 

5,419

 

Gain on sale of dry strip assets and intellectual property

 

(1,167

)

 

Deferred taxes

 

272

 

998

 

Stock-based compensation expense

 

3,105

 

3,411

 

Provision for excess inventory

 

2,451

 

678

 

Changes in operating assets & liabilities

 

 

 

 

 

Accounts receivable

 

(4,359

)

10,143

 

Inventories

 

3,455

 

(3,496

)

Prepaid expenses and other current assets

 

(429

)

4,490

 

Accounts payable and other current liabilities

 

6,276

 

(11,601

)

Deferred revenue

 

(2,816

)

(5,089

)

Income taxes

 

(14

)

(135

)

Other assets and liabilities

 

(3,813

)

3,025

 

Net cash used for operating activities

 

(10,849

)

(11,373

)

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Proceeds from sale of dry strip assets and intellectual property

 

1,200

 

 

Expenditures for property, plant, and equipment

 

(484

)

(536

)

(Increase) decrease in restricted cash

 

(1,477

)

1

 

Net cash used for investing activities

 

(761

)

(535

)

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Increase in restricted cash

 

(825

)

 

Financing fees and other expenses

 

(473

)

 

Proceeds from exercise of stock options

 

1,113

 

863

 

Proceeds from Employee Stock Purchase Plan

 

197

 

179

 

Proceeds from issuance of Term Loan

 

15,000

 

 

Net cash provided by financing activities

 

15,012

 

1,042

 

Effect of exchange rate changes on cash

 

(71

)

(791

)

Net increase (decrease) in cash and cash equivalents

 

3,331

 

(11,657

)

Cash and cash equivalents at beginning of period

 

44,986

 

46,877

 

Cash and cash equivalents at end of period

 

$

48,317

 

$

35,220